Inflammatory breast cancer Clinical presentation Value of combined treatments
Over a total of 1152 patients carrying breas/ cancer whowere treated between 1978 and 1988, 41 cases (3,5%)corresponded to the inf/ammatory variety Their agesranged between 26 and 73 years; 15 (63,5 %) werefound in postmenopausica/ women. From the clinicalpoint of view, in 34, 1 % of the cases the d...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | article |
| Language: | Spanish |
| Published: |
1995
|
| Subjects: | |
| Online Access: | https://revista.scu.org.uy/index.php/cir_urug/article/view/4190 |
| Tags: |
No Tags, Be the first to tag this record!
|
| Summary: | Over a total of 1152 patients carrying breas/ cancer whowere treated between 1978 and 1988, 41 cases (3,5%)corresponded to the inf/ammatory variety Their agesranged between 26 and 73 years; 15 (63,5 %) werefound in postmenopausica/ women. From the clinicalpoint of view, in 34, 1 % of the cases the disease waslimited to the breast exclusive/y; 48, 7% presentedregional invasion of nades and the remainig 17%presented disseminated disease. lnitial treatmentconsisted of 3-4 chemotherapy cycles of the FAC typeexcept in the case of elderly patients who a/so receivedCMF association. Al/ of them were la ter radiated withdoses of 5000-6000 cGy over breas/ and nadeterritories. Treatment ended with 6 to 8 additionalchemoterapy cycles. None of the patients underwentsurgery. Median survival of the whole population was of22 months (26 far premenopausica/ patients and 15 farthe postmenopausical ones). Recidive percentage roseas 30%, 45% of the localized forms disseminated in theevolution. The authors emphasize the fact that thetherapeutical strategy was based on chemo-radiotherapyassociation; there is a possibility of management withhigh doses of cytostatic agents with or without bonemarrow transplant. |
|---|